Ysura has developed a customer interaction platform for the sales and marketing departments of pharmaceutical companies. It is designed to ensure an optimal experience for every user in every conversation. The solution includes a CRM offering and advanced features that can be integrated with external systems. It also provides access to the "Yroom," an advanced video technology solution.
“The user-centric platform enables sales representatives to provide each healthcare representative with the right information at the right time through the right channel,”
explained Philip Debbas, CEO of Ysura. And further:
"Our products are developed in-house with usability as our top priority. They are highly intuitive and unconstrained by a third-party backbone, providing unmatched functionality and flexibility."
With the capital raised, Ysura plans to hire additional employees at its locations in Munich and Spain over the next twelve months. In addition, the startup to further develop its solution and expand its consulting services. The Munich-based pharmaceutical company aims to provide even better support in the transition to an omnichannel organization.
Marondo “immediately impressed” by Ysura
Financier Marondo is convinced of the Munich-based company. Stefan Elsser, partner and co-founder of Marondo Capital, says:
"The clear focus on the pharmaceutical industry, coupled with a focus on real needs and continuous innovation, is reflected in the functionality and ergonomics of Ysura's products. We were immediately impressed by the cloud-based offerings, multi-tiered architecture, and business logic."
And Marko Maschek, also a partner and co-founder of Marondo, adds:
"Ysura is transforming the way pharmaceutical representatives can deliver more value to HCPs. We look forward to Ysura's continued success as it becomes the partner of choice in Europe in a rapidly changing pharmaceutical sales and marketing ecosystem."
